# FDA Inspection 1287196 - Liquipak Corp. - October 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/liquipak-corp/a5d487a0-1edf-4f55-b357-04d3e9ca72e0
Source feed: FDA_Inspections

> FDA Inspection 1287196 for Liquipak Corp. on October 16, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287196
- Company Name: Liquipak Corp.
- Inspection Date: 2025-10-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Detroit District Office

## Related Documents

- [FDA Inspection 1070634 - 2018-11-01](https://www.keypedia.com/records/fda_inspections/liquipak-corp/9b7414fd-2a24-41d6-9c41-1a07b9559122)
- [FDA Inspection 860780 - 2013-12-20](https://www.keypedia.com/records/fda_inspections/liquipak-corp/7cfcb743-9161-4f47-936c-841e22fa29ac)

Company: https://www.keypedia.com/companies/liquipak-corp/d2b2f45d-157b-4209-bb6b-ba9e7b47c059

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03